Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Lower cortical serotonin 2A receptors in major depressive disorder, suicide and in rats after administration of imipramine.

Dean B, Tawadros N, Seo MS, Jeon WJ, Everall I, Scarr E, Gibbons A.

Int J Neuropsychopharmacol. 2014 Jun;17(6):895-906. doi: 10.1017/S1461145713001648. Epub 2014 Feb 4.

PMID:
24495390
2.

Changes in Muscarinic M2 Receptor Levels in the Cortex of Subjects with Bipolar Disorder and Major Depressive Disorder and in Rats after Treatment with Mood Stabilisers and Antidepressants.

Gibbons AS, Jeon WJ, Scarr E, Dean B.

Int J Neuropsychopharmacol. 2016 Apr 20;19(4). pii: pyv118. doi: 10.1093/ijnp/pyv118. Print 2016 Apr.

3.

Lower [3H]LY341495 binding to mGlu2/3 receptors in the anterior cingulate of subjects with major depressive disorder but not bipolar disorder or schizophrenia.

McOmish CE, Pavey G, Gibbons A, Hopper S, Udawela M, Scarr E, Dean B.

J Affect Disord. 2016 Jan 15;190:241-248. doi: 10.1016/j.jad.2015.10.004. Epub 2015 Oct 23.

PMID:
26521087
4.

Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects.

Gibbons AS, Scarr E, McLean C, Sundram S, Dean B.

J Affect Disord. 2009 Aug;116(3):184-91. doi: 10.1016/j.jad.2008.11.015. Epub 2008 Dec 21.

5.

Changes in cortical N-methyl-D-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicide.

Dean B, Gibbons AS, Boer S, Uezato A, Meador-Woodruff J, Scarr E, McCullumsmith RE.

Aust N Z J Psychiatry. 2016 Mar;50(3):275-83. doi: 10.1177/0004867415586601. Epub 2015 May 26.

PMID:
26013316
6.

Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment.

Muguruza C, Miranda-Azpiazu P, Díez-Alarcia R, Morentin B, González-Maeso J, Callado LF, Meana JJ.

Neuropharmacology. 2014 Nov;86:311-8. doi: 10.1016/j.neuropharm.2014.08.009. Epub 2014 Aug 20.

PMID:
25150943
7.

Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders.

Dean B, Gibbons AS, Tawadros N, Brooks L, Everall IP, Scarr E.

Mol Psychiatry. 2013 Jul;18(7):767-73. doi: 10.1038/mp.2012.95. Epub 2012 Jul 17.

PMID:
22801413
8.

AMPA receptor expression is increased post-mortem samples of the anterior cingulate from subjects with major depressive disorder.

Gibbons AS, Brooks L, Scarr E, Dean B.

J Affect Disord. 2012 Feb;136(3):1232-7. doi: 10.1016/j.jad.2011.10.001. Epub 2011 Oct 28.

9.

[Efficacy of atypical antipsychotics in depressive syndromes].

Quintin P, Thomas P.

Encephale. 2004 Nov-Dec;30(6):583-9. Review. French.

PMID:
15738862
10.

Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin.

Watanabe Y, Sakai RR, McEwen BS, Mendelson S.

Brain Res. 1993 Jun 25;615(1):87-94.

PMID:
8364729
11.
12.

Increased DOI-induced wet-dog shakes in adrenocorticotropic hormone-treated rats are not affected by chronic imipramine treatment: possible involvement of enhanced 5-HT(2A)-receptor expression in the frontal cortex.

Kitamura Y, Shibata K, Akiyama K, Kimoto S, Fujitani Y, Kitagawa K, Kanzaki H, Ouchida M, Shimizu K, Kawasaki H, Sendo T, Gomita Y.

J Pharmacol Sci. 2008 Jan;106(1):100-6. Epub 2008 Jan 11.

13.

The influences of reserpine and imipramine on the 5-HT2 receptor binding site and its coupled second messenger in rat cerebral cortex.

Lee MJ, Wei JW.

Chin J Physiol. 2013 Aug 31;56(4):199-208. Erratum in: Chin J Physiol. 2013 Oct 31;56(5):306.

PMID:
23806035
14.

Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.

Qesseveur G, Petit AC, Nguyen HT, Dahan L, Colle R, Rotenberg S, Seif I, Robert P, David D, Guilloux JP, Gardier AM, Verstuyft C, Becquemont L, Corruble E, Guiard BP.

Neuropharmacology. 2016 Jun;105:142-153. doi: 10.1016/j.neuropharm.2015.12.022. Epub 2016 Jan 4.

PMID:
26764241
15.
16.

Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.

Uezato A, Meador-Woodruff JH, McCullumsmith RE.

Bipolar Disord. 2009 Nov;11(7):711-25. doi: 10.1111/j.1399-5618.2009.00752.x.

PMID:
19839996
17.

Cortisol level in men with major depressive disorder treated with fluoxetine or imipramine.

Piwowarska J, Dryll K, Szelenberger W, Pachecka J.

Acta Pol Pharm. 2008 Jan-Feb;65(1):159-64.

18.

Effects of antidepressant drug exposure on gene expression in the developing cerebral cortex.

Tsapakis EM, Fernandes C, Moran-Gates T, Basu A, Sugden K, Aitchison KJ, Tarazi FI.

Synapse. 2014 May;68(5):209-20. doi: 10.1002/syn.21732. Epub 2014 Feb 13.

PMID:
24458505
19.

Neuron density and serotonin receptor binding in prefrontal cortex in suicide.

Underwood MD, Kassir SA, Bakalian MJ, Galfalvy H, Mann JJ, Arango V.

Int J Neuropsychopharmacol. 2012 May;15(4):435-47. doi: 10.1017/S1461145711000691. Epub 2011 May 9.

20.

Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study.

Machado-Vieira R, Zanetti MV, Otaduy MC, De Sousa RT, Soeiro-de-Souza MG, Costa AC, Carvalho AF, Leite CC, Busatto GF, Zarate CA Jr, Gattaz WF.

J Clin Psychopharmacol. 2017 Feb;37(1):40-45. doi: 10.1097/JCP.0000000000000616.

PMID:
27902528

Supplemental Content

Support Center